Trimethylamine-N-oxide: A link between the gut microbiome, bile acid metabolism, and atherosclerosis

Current Opinion in Lipidology

Volumn 27, Issue 2, 2016, Pages 148-154

  Wilson, Aze ^a   McLean, Cheynne ^a   Kim, Richard B ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

bile acid; farnesoid X receptor; flavin monooxygenase 3; Keywords atherosclerosis; trimethylamine N oxide

Indexed keywords

BILE ACID; FARNESOID X RECEPTOR; FLAVIN MONOOXYGENASE 3; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE; DIMETHYLANILINE MONOOXYGENASE (N-OXIDE FORMING); METHYLAMINE; OXYGENASE; TRIMETHYLOXAMINE;

ATHEROSCLEROSIS; BILE ACID METABOLISM; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE COURSE; ENZYME ACTIVITY; GLUCOSE METABOLISM; HUMAN; INTESTINE FLORA; LIPID METABOLISM; METABOLOMICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; FIRMICUTES; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; BILE ACIDS AND SALTS; FIRMICUTES; GASTROINTESTINAL MICROBIOME; HUMANS; METHYLAMINES; OXYGENASES;

EID: 84960334018     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000274     Document Type: Review

References (44)

1. Zheng X, Xie G, Zhao A, et al. The footprints of gut microbial-mammalian cometabolism. J Proteome Res 2011; 10: 5512-5522
2. Fan M, Wang X, Xu G, et al. Bile acid signaling and liver regeneration. Biochim Biophys Acta 2015; 1849: 196-200
3. Craciun S, Balskus EP. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci U S A 2012; 109: 21307-21312
4. Zeisel SH, Wishnok JS, Blusztajn JK. Formation of methylamines from ingested choline and lecithin. J Pharmacol Exp Ther 1983; 225: 320-324
5. Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite. MBio 2015; 6: e02481-02414
6. Cashman JR, Akerman BR, Forrest SM, Treacy EP. Population-specific polymorphisms of the human FMO3 gene: significance for detoxication. Drug Metab Dispos 2000; 28: 169-173
7. Krueger SK, Williams DE. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 2005; 106: 357-387
8. Treacy EP, Akerman BR, Chow LM, et al. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum Mol Genet 1998; 7: 839-845
9. Messenger J, Clark S, Massick S, Bechtel M. A review of trimethylaminuria: (fish odor syndrome). J Clin Aesthet Dermatol 2013; 6: 45-48
10. Wang Z, Levison BS, Hazen JE, et al. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal Biochem 2014; 455: 35-40
11. Agustsson I, Strøm A. Biosynthesis and turnover of trimethylamine oxide in the teleost cod, Gadus morhua. J Biol Chem 1981; 256: 8045-8049
12. Gillett MB, Suko JR, Santoso FO, Yancey PH. Elevated levels of trimethylamine oxide in muscles of deep-sea gadiform teleosts: a high-pressure adaptation?. J Exp Zool 1997; 279: 386-391
13. Seibel BA, Walsh PJ. Trimethylamine oxide accumulation in marine animals: relationship to acylglycerol storage. J Exp Biol 2002; 205: 297-306
14. Zou Q, Bennion BJ, Daggett V, Murphy KP. The molecular mechanism of stabilization of proteins by TMAO and its ability to counteract the effects of urea. J Am Chem Soc 2002; 124: 1192-1202
15. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of lcarnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19: 576-585
16. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63
17. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368: 1575-1584
18. Tang WH, Wang Z, Kennedy DJ, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 2015; 116: 448-455
19. Stubbs JR, House JA, Ocque AJ, et al. Serum trimethylamine-n-oxide is elevated in ckd and correlates with coronary atherosclerosis burden. J Am Soc Nephrol 2015. [Epub ahead of print]
20. Kaysen GA, Johansen KL, Chertow GM, et al. Associations of trimethylamine n-oxide with nutritional and inflammatory biomarkers and cardiovascular outcomes in patients new to dialysis. J Ren Nutr 2015; 25: 351-356
21. Gregory JC, Buffa JA, Org E, et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem 2015; 290: 5647-5660
22. Gao X, Liu X, Xu J, et al. Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J Biosci Bioeng 2014; 118: 476-481
23. Shih DM, Wang Z, Lee R, et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J Lipid Res 2015; 56: 22-37
24. Charach G, Rabinovich PD, Konikoff FM, et al. Decreased fecal bile acid output in patients with coronary atherosclerosis. J Med 1998; 29: 125-136
25. Charach G, Grosskopf I, Rabinovich A, et al. The association of bile acid excretion and atherosclerotic coronary artery disease. Therap Adv Gastroenterol 2011; 4: 95-101
26. Charach G, Rabinovich A, Argov O, et al. The role of bile acid excretion in atherosclerotic coronary artery disease. Int J Vasc Med 2012; 2012: Article 949672
27. Lu Y, Feskens EJM, Boer JMA, Müller M. The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population. Atherosclerosis 2010; 210: 14-27
28. Bennett BJ, De Aguiar Vallim TQ, Wang Z, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab 2013; 17: 49-60
29. Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile Acids the Gut Microbiome. Curr OpinGastroenterol 2014; 30: 332-338
30. Islam KS, Fukiya S, Hagio M, et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011; 141: 1773-1781
31. Kakiyama G, Pandak WM, Gillevet PM, et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol 2013; 58: 949-955
32. Bajaj JS, Heuman DM, Hylemon PB, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 2014; 60: 940-947
33. Attinkara R, Mwinyi J, Truninger K, et al. Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease. BMC Res Notes 2012; 5: 12
34. Forman BM, Goode E, Chen J, et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995; 81: 687-693
35. Modica S, Gadaleta RM, Moschetta A. Deciphering the nuclear bile acid receptor FXR paradigm. Nucl Recept Signal 2010; 8: e005
36. Matsubara T, Tanaka N, Patterson AD, et al. Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis. Hepatology 2011; 53: 1282-1293
37. Lee HZY, Lee FY, Nelson SF, et al. FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. J Lipid Res 2006; 47: 14
38. Landrier JFEJ, Vavricka SR, Kullak-Ublick GA. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-a and -b genes. Am J Physiol Gastrointest Liver Physiol 2006; 290: 10
39. Plass JRMO, Heegsma J, Geuken M, et al. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 2002; 35: 8
40. Neimark ECF, Li X, Shneider BL. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Hepatology 2004; 40: 8
41. Eloranta JJJD, Kullak-Ublick GA. The human Na-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism. Mol Endocrinol 2006; 20: 15
42. Goodwin BJS, Price RR, Watson MA, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000; 6: 10
43. Reue K, Lee JM, Vergnes L. Diet1 is a regulator of fibroblast growth factor 15/ 19-dependent bile acid synthesis. Dig Dis 2015; 33: 307-313
44. Dawson PA. Impact of inhibiting ileal apical versus basolateral bile acid transport on cholesterol metabolism and atherosclerosis in mice. Dig Dis 2015; 33: 382-387